Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1955 1
1956 1
1957 4
1958 1
1959 3
1960 2
1961 4
1962 7
1963 5
1964 10
1965 9
1966 5
1967 3
1968 8
1969 3
1970 1
1971 5
1972 6
1973 6
1974 6
1975 7
1976 11
1977 6
1978 6
1979 20
1980 24
1981 19
1982 25
1983 25
1984 30
1985 40
1986 55
1987 69
1988 90
1989 85
1990 91
1991 95
1992 115
1993 135
1994 169
1995 175
1996 234
1997 243
1998 263
1999 271
2000 356
2001 412
2002 464
2003 672
2004 797
2005 1032
2006 1241
2007 1385
2008 1587
2009 1869
2010 2247
2011 2688
2012 3187
2013 3804
2014 4382
2015 5127
2016 5423
2017 6064
2018 7008
2019 7813
2020 9614
2021 10908
2022 13070
2023 13042
2024 15476
2025 17959
2026 9087

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133,532 results

Results by year

Filters applied: . Clear all
Page 1
Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.
Wu YL, Hochmair M, Yang Y, Yang XN, Tsuboi M, Paz-Ares L, Yang JC, Wu L, Kim HR, Rieke DT, Johnson M, Besse B, Sharma N, Maeda P, Peterson P, Lin BK, Frimodt-Moller B, Goldman J, Drilon A; LIBRETTO-432 Trial Investigators. Wu YL, et al. Among authors: yang y. N Engl J Med. 2026 May 31. doi: 10.1056/NEJMoa2602628. Online ahead of print. N Engl J Med. 2026. PMID: 42223087
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.
Xiong A, Yao W, Zheng W, Yu Y, Chen P, Zhong H, Ge J, Wang H, Chen B, Wang H, Fan Y, Yang Y, Pu X, Song X, Wang Q, Du X, Huang Z, Li X, Luo H, Yao Y, Yu Q, Su C, He L, Jiang G, Cui J, Liu C, Yi T, Che G, Liu Z, Zhang L, Zhou M, Fang Y, Wei Y, Qing Y, Jin X, Zhou C. Xiong A, et al. Among authors: yang y. Lancet. 2026 May 29:S0140-6736(26)00968-2. doi: 10.1016/S0140-6736(26)00968-2. Online ahead of print. Lancet. 2026. PMID: 42214392
Thermal Utilization on Chip.
Zhang Y, Lai B, Yu F, Li X, Yang Y, Lü W, Jiang K, Sun X, Li D. Zhang Y, et al. Among authors: yang y. Light Sci Appl. 2026 Jun 2;15(1):261. doi: 10.1038/s41377-026-02326-1. Light Sci Appl. 2026. PMID: 42230561 Free PMC article.
[Histone deacetylases and alcohol-related liver disease].
Yang Y, Yu M, Liu D, Tan Y. Yang Y, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026 Feb 28;51(2):202-212. doi: 10.11817/j.issn.1672-7347.2026.250225. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026. PMID: 42244312 Free PMC article. Review. Chinese.
133,532 results
You have reached the last available page of results. Please see the User Guide for more information.